Literature DB >> 18779660

Essential role of brc-2 in chromosome integrity of germ cells in C. elegans.

Eunkyong Ko1, Junho Lee, Hyunsook Lee.   

Abstract

brc-2, an ortholog of BRCA2 in Caenorhabditis elegans, is essential in the maintenance of genetic integrity. In C. elegans, cellular location correlates with meiotic progression, and transgene-induced cosuppression is observed in the germ line but not in somatic cells. We used these unique features to dissect the role of brc-2 in the germ line from that in somatic cells. In situ hybridization of wild type animals revealed that brc-2 gene expression was higher in oocytes than in other germline cells, and was barely detectable in mitotic cells. In contrast, germ cells containing multicopies of the brc-2 transgene showed no significant in situ hybridization signal at any oogenesis stage, confirming that brc-2 expression was functionally cosuppressed in the transgenic germ line. RAD-51 foci formation in response to DNA damage was abrogated in brc-2-cosuppressed germ cells, whereas wild-type germ cells showed strong RAD-51 foci formation. These germ cells exhibited massive chromosome fragmentation and decompaction instead of six bivalent chromosomes in diakinesis. Accordingly, lethality was observed after the early stage of germline development. These results suggest that brc-2 plays essential roles in chromosome integrity in early prophase, and therefore is crucial in meiotic progression and embryonic survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18779660

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  8 in total

1.  Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells.

Authors:  Smita Misra; Shvetank Sharma; Anupriya Agarwal; Sheetal V Khedkar; Manish K Tripathi; Mukul K Mittal; Gautam Chaudhuri
Journal:  Mol Cancer       Date:  2010-03-04       Impact factor: 27.401

Review 2.  DNA repair, recombination, and damage signaling.

Authors:  Anton Gartner; JoAnne Engebrecht
Journal:  Genetics       Date:  2022-02-04       Impact factor: 4.402

3.  Exploring the link between MORF4L1 and risk of breast cancer.

Authors:  Griselda Martrat; Christopher M Maxwell; Emiko Tominaga; Montserrat Porta-de-la-Riva; Núria Bonifaci; Laia Gómez-Baldó; Massimo Bogliolo; Conxi Lázaro; Ignacio Blanco; Joan Brunet; Helena Aguilar; Juana Fernández-Rodríguez; Sheila Seal; Anthony Renwick; Nazneen Rahman; Julia Kühl; Kornelia Neveling; Detlev Schindler; María J Ramírez; María Castellà; Gonzalo Hernández; Douglas F Easton; Susan Peock; Margaret Cook; Clare T Oliver; Debra Frost; Radka Platte; D Gareth Evans; Fiona Lalloo; Rosalind Eeles; Louise Izatt; Carol Chu; Rosemarie Davidson; Kai-Ren Ong; Jackie Cook; Fiona Douglas; Shirley Hodgson; Carole Brewer; Patrick J Morrison; Mary Porteous; Paolo Peterlongo; Siranoush Manoukian; Bernard Peissel; Daniela Zaffaroni; Gaia Roversi; Monica Barile; Alessandra Viel; Barbara Pasini; Laura Ottini; Anna Laura Putignano; Antonella Savarese; Loris Bernard; Paolo Radice; Sue Healey; Amanda Spurdle; Xiaoqing Chen; Jonathan Beesley; Matti A Rookus; Senno Verhoef; Madeleine A Tilanus-Linthorst; Maaike P Vreeswijk; Christi J Asperen; Danielle Bodmer; Margreet G E M Ausems; Theo A van Os; Marinus J Blok; Hanne E J Meijers-Heijboer; Frans B L Hogervorst; David E Goldgar; Saundra Buys; Esther M John; Alexander Miron; Melissa Southey; Mary B Daly; Katja Harbst; Ake Borg; Johanna Rantala; Gisela Barbany-Bustinza; Hans Ehrencrona; Marie Stenmark-Askmalm; Bella Kaufman; Yael Laitman; Roni Milgrom; Eitan Friedman; Susan M Domchek; Katherine L Nathanson; Timothy R Rebbeck; Oskar Thor Johannsson; Fergus J Couch; Xianshu Wang; Zachary Fredericksen; Daniel Cuadras; Víctor Moreno; Friederike K Pientka; Reinhard Depping; Trinidad Caldés; Ana Osorio; Javier Benítez; Juan Bueren; Tuomas Heikkinen; Heli Nevanlinna; Ute Hamann; Diana Torres; Maria Adelaide Caligo; Andrew K Godwin; Evgeny N Imyanitov; Ramunas Janavicius; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Sylvie Mazoyer; Carole Verny-Pierre; Laurent Castera; Antoine de Pauw; Yves-Jean Bignon; Nancy Uhrhammer; Jean-Philippe Peyrat; Philippe Vennin; Sandra Fert Ferrer; Marie-Agnès Collonge-Rame; Isabelle Mortemousque; Lesley McGuffog; Georgia Chenevix-Trench; Olivia M Pereira-Smith; Antonis C Antoniou; Julián Cerón; Kaoru Tominaga; Jordi Surrallés; Miguel Angel Pujana
Journal:  Breast Cancer Res       Date:  2011-04-05       Impact factor: 6.466

4.  Homologs of breast cancer genes in plants.

Authors:  Oliver Trapp; Katharina Seeliger; Holger Puchta
Journal:  Front Plant Sci       Date:  2011-06-20       Impact factor: 5.753

5.  A meiosis-specific BRCA2 binding protein recruits recombinases to DNA double-strand breaks to ensure homologous recombination.

Authors:  Jingjing Zhang; Yasuhiro Fujiwara; Shohei Yamamoto; Hiroki Shibuya
Journal:  Nat Commun       Date:  2019-02-13       Impact factor: 14.919

6.  Bioinformatics analysis identify novel OB fold protein coding genes in C. elegans.

Authors:  Daryanaz Dargahi; David Baillie; Frederic Pio
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

7.  Trypanosoma brucei BRCA2 acts in a life cycle-specific genome stability process and dictates BRC repeat number-dependent RAD51 subnuclear dynamics.

Authors:  Anna Trenaman; Claire Hartley; Marko Prorocic; Danielle G Passos-Silva; Moniek van den Hoek; Volodymyr Nechyporuk-Zloy; Carlos R Machado; Richard McCulloch
Journal:  Nucleic Acids Res       Date:  2012-12-07       Impact factor: 16.971

8.  BRCA2 binding through a cryptic repeated motif to HSF2BP oligomers does not impact meiotic recombination.

Authors:  Rania Ghouil; Simona Miron; Lieke Koornneef; Jasper Veerman; Maarten W Paul; Marie-Hélène Le Du; Esther Sleddens-Linkels; Sari E van Rossum-Fikkert; Yvette van Loon; Natalia Felipe-Medina; Alberto M Pendas; Alex Maas; Jeroen Essers; Pierre Legrand; Willy M Baarends; Roland Kanaar; Sophie Zinn-Justin; Alex N Zelensky
Journal:  Nat Commun       Date:  2021-07-29       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.